Chinese Journal of Stroke ›› 2024, Vol. 19 ›› Issue (1): 76-86.DOI: 10.3969/j.issn.1673-5765.2024.01.011
Previous Articles Next Articles
YANG Jiaxin, HE Chunyu, LIU Lei, CHEN Wenbo, XIE Yan
Received:
2023-07-19
Online:
2024-01-20
Published:
2024-01-20
Contact:
HE Chunyu, E-mail: 1125662859@qq.com
杨嘉欣,何春渝,刘蕾,陈文博,谢艳
通讯作者:
何春渝 1125662859@qq.com
CLC Number:
YANG Jiaxin, HE Chunyu, LIU Lei, CHEN Wenbo, XIE Yan. Prediction Models of Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke: A Systematic Review[J]. Chinese Journal of Stroke, 2024, 19(1): 76-86.
杨嘉欣, 何春渝, 刘蕾, 陈文博, 谢艳. 急性缺血性卒中静脉溶栓后症状性颅内出血预测模型的系统评价[J]. 中国卒中杂志, 2024, 19(1): 76-86.
[1] GBD 2019 Stroke Collaborators. Global,regional,and national burden of stroke and its risk factors,1990—2019:a systematic analysis for the global burden of disease study 2019[J]. Lancet Neurol,2021,20(10):795-820. [2] POWERS W J,RABINSTEIN A A,ACKERSON T,et al. Guidelines for the early management of patients with acute ischemic stroke:2019 update to the 2018 guidelines for the early management of acute ischemic stroke:a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J/OL]. Stroke,2019,50(12):e344-e418[2023-06-11]. https://doi.org/10.1161/STR.0000000000000211. [3] BERGER C,FIORELLI M,STEINER T,et al. Hemorrhagic transformation of ischemic brain tissue:asymptomatic or symptomatic?[J]. Stroke,2001,32(6):1330-1335. [4] YAGHI S,WILLEY J Z,CUCCHIARA B,et al. Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke:a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association[J/OL]. Stroke,2017,48(12):e343-e361[2023-06-11]. https://doi.org/10.1161/STR.0000000000000152. [5] HONIG A,PERCY J,SEPEHRY A A,et al. Hemorrhagic transformation in acute ischemic stroke:a quantitative systematic review[J/OL]. J Clin Med,2022,11(5):1162[2023-05-13]. https://doi.org/10.3390/jcm11051162. [6] KAMAL H,LOPEZ V,SHETH S A. Machine learning in acute ischemic stroke neuroimaging [J/OL]. Front Neurol,2018,9:945[2023-05-13]. https://doi.org/10.3389/fneur.2018.00945. [7] SUNG S M,KANG Y J,CHO H J,et al. Prediction of early neurological deterioration in acute minor ischemic stroke by machine learning algorithms[J/OL]. Clin Neurol Neurosurg,2020,195:105892[2023-05-13]. https://doi.org/10.1016/j.clineuro.2020.105892. [8] PAGE M J,MCKENZIE J E,BOSSUYT P M,et al. The PRISMA 2020 statement:an updated guideline for reporting systematic reviews[J/OL]. BMJ,2021,372:n71[2023-05-13]. https://doi.org/10.1136/bmj.n71. [9] MOONS K G,DE GROOT J A,BOUWMEESTER W,et al. Critical appraisal and data extraction for systematic reviews of prediction modelling studies:the CHARMS checklist[J/OL]. PLoS Med, 2014,11(10):e1001744[2023-05-13]. https://doi.org/10.1371/journal.pmed.1001744. [10] WOLFF R F,MOONS K G M,RILEY R D,et al. PROBAST:a tool to assess the risk of bias and applicability of prediction model studies[J]. Ann Intern Med,2019,170(1):51-58. [11] 陈香萍,张奕,庄一渝,等. PROBAST:诊断或预后多因素预测模型研究偏倚风险的评估工具[J]. 中国循证医学杂志,2020,20(6):737-744. CHEN X P,ZHANG Y,ZHUANG Y Y,et al. PROBAST:a tool for assessing risk of bias in the study of diagnostic or prognostic multi-factorial predictive models[J]. Chin J Evid-Based Med,2020,20(6):737-744. [12] National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke[J]. N Engl J Med,1995,333(24):1581-1587. [13] HACKE W,KASTE M,FIESCHI C,et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke(ECASS Ⅱ)[J]. Lancet,1998,352(9136):1245-1251. [14] HACKE W,KASTE M,BLUHMKI E,et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke[J]. N Engl J Med,2008,359(13):1317-1329. [15] WAHLGREN N,AHMED N,DÁVALOS A,et al. Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in stroke-monitoring study(SITS-MOST):an observational study[J]. Lancet,2007,369(9558):275-282. [16] ASUZU D,NYSTRÖM K,AMIN H,et al. TURN:a simple predictor of symptomatic intracerebral hemorrhage after Ⅳ thrombolysis[J]. Neurocrit Care,2015,23(2):166-171. [17] CAPPELLARI M,TURCATO G,FORLIVESI S,et al. STARTING-SICH nomogram to predict symptomatic intracerebral hemorrhage after intravenous thrombolysis for stroke[J]. Stroke,2018,49(2):397-404. [18] CHUNG C C,CHAN L,BAMODU O A,et al. Artificial neural network based prediction of postthrombolysis intracerebral hemorrhage and death[J/OL]. Scientific reports,2020,10(1):20501[2023-05-13]. https://doi.org/10.1038/s41598-020-77546-5. [19] CUCCHIARA B,TANNE D,LEVINE S R,et al. A risk score to predict intracranial hemorrhage after recombinant tissue plasminogen activator for acute ischemic stroke[J]. J Stroke Cerebrovasc Dis,2008,17(6):331-333. [20] DHARMASAROJA P,DHARMASAROJA P A. Prediction of intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke using multiple artificial neural networks[J]. Neurol Res,2012,34(2):120-128. [21] ERDUR H,POLYMERIS A,GRITTNER U,et al. A score for risk of thrombolysis-associated hemorrhage including pretreatment with statins [J/OL]. Front Neurol,2018,9:74[2023-05-13]. https://doi.org/10.3389/fneur.2018.00074. [22] LIU J F,CHEN X Y,GUO X N,et al. Machine learning prediction of symptomatic intracerebral hemorrhage after stroke thrombolysis:a cross-cultural validation in Caucasian and Han Chinese cohort[J/OL]. Ther Adv Neurol Disord,2022,15:81556828[2023-05-13]. https://doi.org/10.1177/17562864221129380. [23] LOKESKRAWEE T,MUENGTAWEEPONGSA S,PATUMANOND J,et al. Prediction of symptomatic intracranial hemorrhage after intravenous thrombolysis in acute ischemic stroke:the symptomatic intracranial hemorrhage score[J]. J Stroke Cerebrovasc Dis,2017,26(11):2622-2629. [24] LOU M,SAFDAR A,MEHDIRATTA M,et al. The HAT score:a simple grading scale for predicting hemorrhage after thrombolysis[J]. Neurology,2008,71(18):1417-1423. [25] MAZYA M,EGIDO J A,FORD G A,et al. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase safe implementation of treatments in stroke(SITS)symptomatic intracerebral hemorrhage risk score[J]. Stroke,2012,43(6):1524-1531. [26] MENON B K,SAVER J L,PRABHAKARAN S,et al. Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator[J]. Stroke,2012,43(9):2293-2299. [27] REN Y,HE Z X,DU X Y,et al. The SON2A2 score:a novel grading scale for predicting hemorrhage and outcomes after thrombolysis[J/OL]. Front Neurol,2022,13:952843[2023-05-13]. https://doi.org/10.3389/fneur.2022.952843. [28] SAPOSNIK G,GUZIK A K,REEVES M,et al. Stroke prognostication using age and NIH stroke scale:SPAN-100[J]. Neurology,2013,80(1):21-28. [29] SONI M,WIJERATNE T,ACKLAND D C. A risk score for prediction of symptomatic intracerebral haemorrhage following thrombolysis[J/OL]. Int J Med Inform,2021,156:104586[2023-05-13]. https://doi.org/10.1016/j.ijmedinf.2021.104586. [30] STRBIAN D,ENGELTER S,MICHEL P,et al. Symptomatic intracranial hemorrhage after stroke thrombolysis:the SEDAN score[J]. Ann Neurol,2012,71(5):634-641. [31] TANNE D,KASNER S E,DEMCHUK A M,et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice:the multicenter rt-PA stroke survey[J]. Circulation,2002,105(14):1679-1685. [32] WAHLGREN N,AHMED N,ERIKSSON N,et al. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials:safe implementation of thrombolysis in stroke-monitoring study(SITS-MOST)[J]. Stroke,2008,39(12):3316-3322. [33] WANG F,HUANG Y H Q,XIA Y,et al. Personalized risk prediction of symptomatic intracerebral hemorrhage after stroke thrombolysis using a machine-learning model [J/OL]. Ther Adv Neurol Disord,2020,13:1756286420902358[2023-05-13]. https://doi.org/10.1177/1756286420902358. [34] WHITELEY W N,THOMPSON D,MURRAY G,et al. Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome[J]. Stroke,2014,45(4):1000-1006. [35] 王莹,陈会生. 阿替普酶溶栓后症状性颅内出血预测模型的构建及验证[J]. 中国脑血管病杂志,2022,19(10):657-666. WANG Y,CHEN H S. Construction and validation of a predictive model for symptomatic intracranial hemorrhage after thrombolytic therapy with alteplase[J]. Chin J Cerebrovasc Dis,2022,19(10):657-666. [36] KRISHNAMURTHI R V,IKEDA T,FEIGIN V L. Global,regional and country-specific burden of ischaemic stroke,intracerebral haemorrhage and subarachnoid haemorrhage:a systematic analysis of the global burden of disease study 2017[J]. Neuroepidemiology,2020,54(2):171-179. [37] SEET R C,RABINSTEIN A A. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke:a critical review of case definitions[J]. Cerebrovasc Dis,2012,34(2):106-114. [38] ECHOUFFO-TCHEUGUI J B,WOODWARD M,KENGNE A P. Predicting a post-thrombolysis intracerebral hemorrhage:a systematic review[J]. J Thromb Haemost,2013,11(5):862-871. [39] KAMAL H,LOPEZ V,SHETH S A. Machine learning in acute ischemic stroke neuroimaging [J/OL]. Front Neurol,2018,9:945[2023-05-13]. https://doi.org/10.3389/fneur.2018.00945. [40] SENDERS J T,STAPLES P C,KARHADE A V,et al. Machine learning and neurosurgical outcome prediction:a systematic review[J/OL]. World Neurosurg,2018,109:476-486,e1[2023-06-11]. https://doi.org/10.1016/j.wneu.2017.09.149. [41] HUANG Y X,LI W T,MACHERET F,et al. A tutorial on calibration measurements and calibration models for clinical prediction models[J]. J Am Med Inform Assoc,2020,27(4):621-633. [42] STEYERBERG E W. Validation in prediction research:the waste by data splitting[J/OL]. J Clin Epidemiol,2018,103:131-133[2023-06-11]. https://doi.org/10.1016/j.jclinepi.2018.07.010. [43] DAS S,MONDAL G P,BHATTACHARYA R,et al. Predictors of postthrombolysis outcome and symptomatic postthrombolysis hemorrhage following intravenous thrombolysis with alteplase for acute ischemic stroke[J]. J Neurosci Rural Pract,2020,11(2):315-324. [44] WNUK M,DRABIK L,DERBISZ J,et al. Prognostic significance of age in patients with acute ischaemic stroke treated with intravenous thrombolysis[J]. Neurol Neurochir Pol,2022,56(1):81-88. [45] FILIPOV A,EBERT A D,NEUMAIER-PROBST E,et al. The burden of diabetes and the chance of a previous stroke:thrombolysis for recurrent stroke in diabetics[J]. J Stroke Cerebrovasc Dis,2018,27(5):1343-1349. [46] DIEDLER J,AHMED N,SYKORA M,et al. Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset[J]. Stroke,2010,41(2):288-294. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||